Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Garcia-Rodriguez

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|October 31, 2024
LIN28 upregulation in primary human T cells impaired CAR T antitumoral activityPatricia Garcia-Rodriguez, Laura Hidalgo, Miguel Angel Rodriguez-Milla, et al.
Dentistry Journal|May 27, 2022
Comparative Evaluation of the Effectiveness of a Combination of Absorbable Gelatin Sponge and <i>Calendula officinalis</i> with Absorbable Gelatin Sponge Used Alone as a Hemostatic Agent-An <i>In-Vitro</i> StudyBharath Kumar Ayyanahalli Matta, Santhosh Kumar, Chetan Hasmukh Mehta, et al.
Cancer Immunology, Immunotherapy : CII|February 12, 2026
Unaltered NKG2D-CAR T cell function under hypoxia in osteosarcoma in vitroLaura Hidalgo, Patricia Garcia-Rodriguez, Isabel Cubillo, et al.
Molecular Therapy. Oncology|September 18, 2024
Deletion of the RGD motif from the penton base in oncolytic adenoviruses enhances antitumor efficacy of combined CAR T cell therapyAlvaro Morales-Molina, Miguel Angel Rodriguez-Milla, Patricia Garcia-Rodriguez, et al.
Experimental Hematology & Oncology|April 3, 2026
Intrinsic immune properties of carrier MSC impact on the clinical outcome of children with solid tumors receiving oncolytic virotherapyAlvaro Morales-Molina, Lidia Franco-Luzón, Patricia Garcia-Rodriguez, et al.
Cancer Immunology, Immunotherapy : CII|April 16, 2023
Switchable CAR T cell strategy against osteosarcomaLaura Hidalgo, Beatriz Somovilla-Crespo, Patricia Garcia-Rodriguez, et al.
Thrombosis Research|March 25, 2014
Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infectionsF J Sherida H Woei-A-Jin, Willize E van der Starre, Margot E T Tesselaar, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|October 31, 2024
LIN28 upregulation in primary human T cells impaired CAR T antitumoral activityPatricia Garcia-Rodriguez, Laura Hidalgo, Miguel Angel Rodriguez-Milla, et al.
Dentistry Journal|May 27, 2022
Comparative Evaluation of the Effectiveness of a Combination of Absorbable Gelatin Sponge and <i>Calendula officinalis</i> with Absorbable Gelatin Sponge Used Alone as a Hemostatic Agent-An <i>In-Vitro</i> StudyBharath Kumar Ayyanahalli Matta, Santhosh Kumar, Chetan Hasmukh Mehta, et al.
Cancer Immunology, Immunotherapy : CII|February 12, 2026
Unaltered NKG2D-CAR T cell function under hypoxia in osteosarcoma in vitroLaura Hidalgo, Patricia Garcia-Rodriguez, Isabel Cubillo, et al.
Molecular Therapy. Oncology|September 18, 2024
Deletion of the RGD motif from the penton base in oncolytic adenoviruses enhances antitumor efficacy of combined CAR T cell therapyAlvaro Morales-Molina, Miguel Angel Rodriguez-Milla, Patricia Garcia-Rodriguez, et al.
Experimental Hematology & Oncology|April 3, 2026
Intrinsic immune properties of carrier MSC impact on the clinical outcome of children with solid tumors receiving oncolytic virotherapyAlvaro Morales-Molina, Lidia Franco-Luzón, Patricia Garcia-Rodriguez, et al.
Cancer Immunology, Immunotherapy : CII|April 16, 2023
Switchable CAR T cell strategy against osteosarcomaLaura Hidalgo, Beatriz Somovilla-Crespo, Patricia Garcia-Rodriguez, et al.
Thrombosis Research|March 25, 2014
Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infectionsF J Sherida H Woei-A-Jin, Willize E van der Starre, Margot E T Tesselaar, et al.
Pageof 1